Literature DB >> 10949600

The fifth Frederick H. Verhoeff Lecture. The role of the lymphocyte (cell-mediated) immunity in ocular disease.

I H Leopold.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 10949600      PMCID: PMC1310492     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


× No keyword cloud information.
  38 in total

1.  STUDY OF SERUM ANTINUCLEAR FACTOR IN UVEITIS.

Authors:  Y KUROSE; J MICHON; I H LEOPOLD
Journal:  Arch Ophthalmol       Date:  1964-12

2.  Homograft sensitivity. An expression of the immunologic origins and consequences of individuality.

Authors:  H S LAWRENCE
Journal:  Physiol Rev       Date:  1959-10       Impact factor: 37.312

3.  Cellular hypersensitivity in penetrating eye injuries.

Authors:  G E Marak; M S Aye; F P Alepa
Journal:  Invest Ophthalmol       Date:  1973-05

4.  Response of peripheral blood lymphocytes from patients with diabetes mellitus to phytohemagglutinin and Candida albicans antigen.

Authors:  A H Ragab; B Hazlett; D H Cowan
Journal:  Diabetes       Date:  1972-08       Impact factor: 9.461

Review 5.  The biological activities of soluble lymphocyte products.

Authors:  E Pick; J L Turk
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

6.  Implantation of a foetal thymus, restoring immunological competence in a patient with thymic aplasia (Digeorge's syndrome).

Authors:  C S August; F S Rosen; R M Filler; C A Janeway; B Markowski; H E Kay
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

7.  Discussion of lymphocyte transformation.

Authors:  K Hirschhorn
Journal:  Fed Proc       Date:  1968 Jan-Feb

8.  Uveal autoantibody in ocular disease.

Authors:  S B Aronson; D C Schnellmann; E A Yamamoto
Journal:  JAMA       Date:  1966-04-18       Impact factor: 56.272

9.  Cell-mediated immunity in Herpesvirus hominis infections.

Authors:  J M Wilton; L Ivanyi; T Lehner
Journal:  Br Med J       Date:  1972-03-18

10.  Production and characterization of migration inhibitory factor(s) (MIF) of established lymphoid and non-lymphoid cell lines.

Authors:  P S Papageorgiou; W L Henley; P R Glade
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.